tiprankstipranks
Guardant Health price target lowered to $30 from $40 at Piper Sandler
PremiumThe FlyGuardant Health price target lowered to $30 from $40 at Piper Sandler
2M ago
Guardant Health price target lowered to $37 from $44 at TD Cowen
PremiumThe Fly
Guardant Health price target lowered to $37 from $44 at TD Cowen
2M ago
Guardant Health price target lowered to $35 from $38 at BofA
PremiumThe Fly
Guardant Health price target lowered to $35 from $38 at BofA
2M ago
Guardant Health price target lowered to $54 from $64 at Craig-Hallum
PremiumThe FlyGuardant Health price target lowered to $54 from $64 at Craig-Hallum
3M ago
Guardant Health’s preliminary Q4 results well ahead of consensus, says Canaccord
PremiumThe Fly
Guardant Health’s preliminary Q4 results well ahead of consensus, says Canaccord
3M ago
Guardant Health sees FY23 revenue $562M-$563M, consensus $555.18M
PremiumThe Fly
Guardant Health sees FY23 revenue $562M-$563M, consensus $555.18M
3M ago
Guardant Health announces tentative date of FDA panel review of Shield test
PremiumThe FlyGuardant Health announces tentative date of FDA panel review of Shield test
4M ago
Guardant Health initiated with neutral view at Guggenheim, here’s why
PremiumThe Fly
Guardant Health initiated with neutral view at Guggenheim, here’s why
4M ago
Guardant Health initiated with neutral view at Wolfe Research, here’s why
PremiumThe Fly
Guardant Health initiated with neutral view at Wolfe Research, here’s why
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100